Not audited financial statements of AS "Latvijas balzams"

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Not audited financial statements of AS "Latvijas balzams" for year 2014

  The Company was established in 1900 and operates under the current name since 1970. Due to SPI Group internal reorganization the major shareholder of JSC Latvijas balzams from October 2014 is AMBER BEVERAGE GROUP LLC which owns 89.53% of the Company’s equity capital.

  JSC Latvijas balzams is the largest producer of alcoholic beverages in the Baltic States with a range of more than 100 different products. 73% of our production is exported to more than 160 export markets, as mediated by SPI Group, and an additional 30 markets via the Company`s direct export route.

The Company`s Activity in 2014

  The unaudited turnover of the Company in 2014 was 73.7 million Euros, which is 4.8% more than in 2013. The growth of turnover influenced by significant increase in sales in export markets, for example, orders of SPI Group has increased by 6.4%. The most significant increase in sales was achieved in the Baltic countries (+22%) and Norway (+5%), and also in Travel Retail and Duty free market (+8%). Continuing purposeful growth in strategically significant markets, the Company has successfully expanded assortment and developed in China`s market, and also led the foundation for future growth in the USA and UK markets.

  The unaudited profit for the reporting period reached 7.1 million Euros, which represents 14% growth versus 2013. The result was achieved through focused development of the beverage portfolio, volume growth in strategically significant export markets and production process efficiency.

  During 2014, JSC Latvijas balzams paid 53.5 million Euros into the state budget, including excise tax, amounting to 39.2 million Euros.

  Outlook of Future Activities

  The Company will continue purposeful focus on achieve of settled objectives in both domestic and export markets. Our priorities still will be beverage portfolio consummate with the focus on exportable beverages and internationally acknowledged brands, as well as focus on implementation of effective production strategy to increase the Company`s competitiveness.

   In cooperation with subsidiary company Daugavgrivas 7 LLC, the Company is planning in the future to set up the museum and show rooms to promote the dialogue with consumers and give the opportunity to present the JSC Latvijas balzams produced brands and their history.

  By active participation in the Industry Association and cooperating with non-governmental organizations, the Company will represent the interests of industry in the dialogue with legislators and law enforcement institutions, and promote advised policy development in the alcohol market. The Company will continue to focus on activities of combating non-commercial alcoholic beverages and to focus on the public education on these issues.

JSC „Latvijas balzams”

Chairman of the Board                                                                            Guntis Āboltiņš - Āboliņš

Riga, February 27th, 2015

Further information:

 Income statement for the period ended December 31, 2014

    01.01.2014 - 31.12.2014 01.01.2013 - 31.12.2013
            EUR         EUR
       
Revenue 1           73 745 723             70 368 874
Cost of sales 2         (57 582 564)           (56 221 488)
Gross profit          16 163 159          14 147 386
Distribution expenses 3           (4 962 416)             (4 126 709)
Administrative expenses 4           (3 705 767)             (3 438 379)
Other income                  776 914                  260 117
Other expenses                (172 685)                (168 474)
Finance income               1 433 979               1 342 334
Finance costs                (765 746)                (758 152)
Profit before tax             8 767 439             7 258 123
Corporate income tax              (1 665 813)             (1 029 364)
Net profit              7 101 625             6 228 759

  Balance sheet as at December 31, 2014

  2014.12.31 2013.12.31
ASSETS EUR EUR
     
Non-current assets    
Intangible assets                 399 301                       209 956
Property, plant and equipment            18 875 280                  18 888 414
Loans to group companies            43 566 129                  37 051 670
Other non-current assets                   34 149                         34 149
Total non-current assets:          62 874 858                56 184 189
     
Current assets    
Inventories            22 839 335                  21 361 814
Trade receivables              1 472 185                       930 195
Receivables from group companies            44 667 753                  52 018 765
Other current assets                 738 508                       550 816
Corporate income tax                             -                       220 199
Cash and cash equivalents                 392 182                         25 740
Total current assets:          70 109 963                75 107 529
     
Total assets   132 984 822       131 291 718
     
     
EQUITY AND LIABILITIES    
     
Equity    
Share capital            10 667 128                  10 667 128
Share premium                   87 887                         87 887
Revaluation reserves of non-current assets            12 600 197                  12 600 197
Retained earnings            63 856 692                  56 755 065
Total equity:          87 211 903                80 110 276
     
Liabilities:    
Non-current liabilities:    
Borrowings              6 871 863                    3 037 518
Deferred income tax liabilities              1 863 986                    1 863 986
 Total non-current liabilities:            8 735 849                  4 901 504
     
Current liabilities:    
Borrowings            15 669 753                  22 301 560
Other borrowings                   73 128                                   -
Trade payables              2 256 882                    5 666 743
Payables to group companies              1 547 117                    3 051 045
Current corporate income tax payables                 438 346                                   -
Other liabilities            17 051 844                  15 260 590
Total current liabilities:          37 037 070                46 279 938
     
Total liabilities:     45 772 919         51 181 442
     
Total equity and liabilities:   132 984 822       131 291 718

         Inta Belova          Finance Manager          Tel.nr.67011715          e-mail Inta.belova@lb.lv

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 74

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 4

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 48

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AAI Rolls Out Agency Gauge: AI-Driven Insights Platform

Updated Category News Views 2

Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 7

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 42

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Dickinson Brands Celebrates Witch Hazel Legacy with Event

Updated Category News Views 5

Witch Hazel's Timeless Appeal You don’t get to celebrate over one and a half centuries of a product without doing something right. Dickinson Brands Inc. is throwing a bash worth noticing as they mark the sixth annual National Witch Hazel Day on October 21st. It’s a head-nod to the versatile witch hazel, a product that’s been part of New England's heritage since the...

Continue Reading
Cancer Memoir Shows Healing Beyond Medicine

Updated Category News Views 2

Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 61

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Venue Two Eleven: Historic Charm Meets Modern Events

Updated Category News Views 5

Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Investor Sentiment on Novo Nordisk Options Trading

Updated Category News Views 120

Investor Insights into Novo Nordisk Options Trading In the dynamic landscape of stock trading, the behavior of high-value investors often reveals critical insights into future market movements. Recently, attention has shifted toward Novo Nordisk (NYSE: NVO), where wealthy investors have exhibited a notably bearish outlook. This significant trend is something that small...

Continue Reading
Understanding Patient Concerns About Cancer Diagnoses

Updated Category News Views 104

Insights from Ibex Medical Analytics on Cancer Diagnoses A recent survey has shed light on the fears and uncertainties many patients encounter when faced with potential cancer diagnoses. Ibex Medical Analytics, known for its innovative use of artificial intelligence (AI) in cancer diagnostics, identified key findings that highlight the emotions and perceptions of...

Continue Reading
OpenAI Partners with Samsung and SK Hynix: AI Impacts Market

Updated Category News Views 198

OpenAI's Revolutionary Memory Deal In a significant move, OpenAI has established a preliminary agreement with major players in the tech industry, specifically South Korean giants Samsung Electronics Co Ltd and SK Hynix. This partnership is poised to reshape the landscape of artificial intelligence (AI) by addressing critical memory needs for AI systems. Significance of...

Continue Reading
Worksport's Terravis Energy Set to Transform Heat Pump Technology

Updated Category News Views 208

Innovative Heat Pump Technology by Worksport's Terravis Energy Worksport Ltd. (NASDAQ: WKSP) is making significant strides in the clean technology space with its subsidiary Terravis Energy. This innovative company is focused on the development of cutting-edge heat pump technologies that are gaining attention in the multi-billion-dollar market. Exciting Partnership with...

Continue Reading
Ascom's 2024 Challenges and Future Growth Plans Revealed

Updated Category News Views 285

Ascom’s 2024 Financial Overview Ascom recently reported its financial results for 2024, showcasing a mix of challenges and opportunities for growth despite a declining revenue stream. The company's net revenue reached CHF 286.7 million, reflecting a decrease compared to the CHF 297.3 million achieved in 2023. This decline equates to a 1.6% decrease when looking at...

Continue Reading